Modelling the climate impact of inhalers and mitigation strategies: a population-based study in British Columbia, Canada (2015–2032)
High quality, guideline-directed diagnosis and management of respiratory disease is known to improve health and reduce emissions. Building on these benefits, our analysis shows that substituting pMDIs with lower-emission inhalers, when guided by policy and clinical decisions that prioritise patient safety and preference, can significantly reduce healthcare-related GHG emissions.
Authors
- Kate Smolina (ORCID: https://orcid.org/0000-0001-5214-4776)
- Kevin Liang (ORCID: https://orcid.org/0000-0003-3470-8456)
- Gillian Frosst (ORCID: https://orcid.org/0000-0003-1744-9923)
- Solmaz Setayeshgar (ORCID: https://orcid.org/0000-0003-3467-8381)
- Valeria Stoynova
Institutions
- University of British Columbia (CA)
- BC Centre for Disease Control (CA)
Publication Details
- Journal
- BMJ Open Respiratory Research
- Published
- 2025-10-01
- DOI
- https://doi.org/10.1136/bmjresp-2025-003218
- Primary Topic
- Inhalation and Respiratory Drug Delivery
- Type
- article
- Field-Weighted Citation Impact
- 0.00